Shift Bioscience Bags $16m to Develop Novel Therapies for Age-related Diseases nextdigitalhealth.com
Shift Bioscience, a biotechnology startup using generative AI to explore how gene activation can reverse the aging process, has secured $16 million in seed funding to further develop its cell simulation AI platform.
The funding round was led by BGF, with significant contributions from Kindred Capital, F-Prime Capital, and Jonathan Milner.
Report Story
4 Comments
72 SPS should be discontinued in patients who become constipated, and repeat doses should not be given to patients who have not passed a bowel movement how to take priligy I had to go in anyway that day, and the doctor saw it was an extremely overactive corpus luteum producing fluid
Yesterday, while I was at work, my cousin stole my iphone and tested to see if it can survive a
30 foot drop, just so she can be a youtube sensation. My
iPad is now destroyed and she has 83 views. I know this is totally
off topic but I had to share it with someone!
buy priligy Domont J, Salas S, Lacroix L, et al
Based on the lag time analyses, we believe that the association with improved survival of desloratadine and loratadine is not artefactual, however, we cannot here draw the same conclusions regarding the possibly negative effects of clemastine and cetirizine, and the cationic amphiphilic properties of desloratadine, loratadine and ebastine may explain some of their potential effect what does augmentin treat Specific inhibition of acetylcholine release from the presynaptic terminal by botulinum toxin, hypermagnesemia, or aminoglycoside antibiotics may also occur